Ropivacaine pharmacokinetics after caudal block in 1-8 year old children

British Journal of Anaesthesia

Volumn 85, Issue 4, 2000, Pages 506-511

  Lonnqvist P A ^a   Westrin, P ^b   Larsson, B A ^a   Olsson, G L ^a   Lybeck, A ^c   Huledal, G ^c   Bielenstein, M ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Anaesthesia; Anaesthetic techniques; Anaesthetics; Analgesia; Epidural; Local; Paediatric; Pharmacokinetics; Postoperative; Regional; Ropivacaine

Indexed keywords

ATRACURIUM; EMLA; MIDAZOLAM; NITROUS OXIDE; OXYGEN; ROPIVACAINE; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL;

ARTICLE; BLOOD SAMPLING; CAUDAL ANESTHESIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERANCE; FEMALE; HUMAN; MALE; MOTOR NERVE BLOCK; MULTICENTER STUDY; PEDIATRIC ANESTHESIA; PEDIATRIC SURGERY; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; TIME; UMBILICUS; VENOUS BLOOD;

EID: 0033802690     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.4.506     Document Type: Article

References (25)

1. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
2. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: A double-blind study
3. Ropivacaine in paediatric surgery: Preliminary results
4. Comparison of ropivacaine with bupivacaine for paediatric caudal block
5. Ropivacaine vs bupivacaine in major surgery in infants
6. 3]ropivacaine in biological samples by gas chromatography with nitrogen-phosphorus detection or mass spectrometry
7. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography
8. Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites
9. Metabolism and excretion of ropivacaine in humans
10. Age and weight
11. Topical wound anaesthesia in children-a temporary postoperative pain relief
12. The dose-response of caudal ropivacaine in children
13. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients
14. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route
15. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans
16. 1-acid glycoprotein and albumin
17. 1-acid glycoprotein and the binding of lidocaine in pediatric patients
18. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief
19. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers
20. Valoracion del flujo sanguineo portal, en ninos sanos, mediante ecografia Doppler duplex
21. Ropivacaine, a new amide-type local anaesthetic agent is metabolized by cytochromes P450 1A and 3A in human liver microsomes
22. Metabolism of ropivacaine in humans is mediated by CYPIA2 and to a minor extent by CYP3A4-an interaction study with fluvoxamine and ketokonazole as in vivo inhibitors
23. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography
24. Expression of CYP3A in the human liver. Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth